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Homologous recombination (HR) is an important DNA double-
strand break (DSB) repair pathway that copies sequence informa-
tion lost at the break site from an undamaged homologous tem-
plate. This involves the formation of a recombination structure
that is processed to restore the original sequence but also harbors
the potential for crossover (CO) formation between the participat-
ing molecules. Synthesis-dependent strand annealing (SDSA) is an
HR subpathway that prevents CO formation and is thought to
predominate in mammalian cells. The chromatin remodeler ATRX
promotes an alternative HR subpathway that has the potential to
form COs. Here, we show that ATRX-dependent HR outcompetes
RECQ5-dependent SDSA for the repair of most two-ended DSBs in
human cells and leads to the frequent formation of COs, assessed
by measuring sister chromatid exchanges (SCEs). We provide evi-
dence that subpathway choice is dependent on interaction of both
ATRX and RECQ5 with proliferating cell nuclear antigen. We also
show that the subpathway usage varies among different cancer
cell lines and compare it to untransformed cells. We further ob-
serve HR intermediates arising as ionizing radiation (IR)-induced
ultra-fine bridges only in cells expressing ATRX and lacking MUS81
and GEN1. Consistently, damage-induced MUS81 recruitment is
only observed in ATRX-expressing cells. Cells lacking BLM show
similar MUS81 recruitment and IR-induced SCE formation as con-
trol cells. Collectively, these results suggest that the ATRX path-
way involves the formation of HR intermediates whose processing
is entirely dependent on MUS81 and GEN1 and independent of
BLM. We propose that the predominant ATRX-dependent HR sub-
pathway forms joint molecules distinct from classical Holliday
junctions.
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Homologous recombination (HR) is an essential process forthe maintenance of genomic integrity and is vital for diverse
cellular processes, including replication and double-strand break
(DSB) repair during meiosis and in somatic cells. HR relies on
the use of a homologous template for repair to ensure the
faithful restoration of genetic information. DSB repair is chan-
neled to HR by the 5′ to 3′ resection of break ends to generate 3′
single-stranded DNA (ssDNA) overhangs (1). The recombinase
RAD51 is then loaded to ssDNA to direct the homology search
for complementary sequences and the formation of a displace-
ment loop (D-loop) to allow DNA repair synthesis and the re-
covery of the lost sequences (2–4). Repair can subsequently
proceed through one of several distinct subpathways. During
synthesis-dependent strand annealing (SDSA), the extended
break end is displaced from the D-loop and annealed to the
complementary sequence at the noninvading break end. Alter-
natively, the noninvading end anneals to the displaced strand of
the D-loop in a second-end capture step, leading to the forma-
tion of a structure joining the two recombining molecules, which
has been suggested to represent a double Holliday junction
(dHJ) (5). This joint molecule (JM) needs to be untangled to
allow proper chromosome segregation for which distinct mech-
anisms are in place. This structure can be resolved by a nuclease
complex involving MUS81-EME1 (together with SLX1-SLX4)
or by the resolvase GEN1 which induce asymmetrical or sym-
metrical incisions in the two strands at each HJ, giving rise to
both crossover (CO) and non-CO products (6–8). Additionally,
dHJs can be dissolved by the BLM/TOPOIIIα/RMI1/2 (BTR)
complex, where the two HJs migrate toward each other and
merge to form a hemicatenane that is then decatenated by top-
oisomerases, thus separating the two molecules without ex-
change of genetic material (9–11). Under specific circumstances,
a third subpathway termed break-induced replication (BIR) can
mediate conservative DNA synthesis initiated by the D-loop to
copy the entire chromosome arm (12, 13).
Pathways leading to COs in somatic cells are often viewed as
detrimental, as exchanges between homologous chromosomes
can cause loss of heterozygosity (LOH), a contributing factor to
carcinogenesis. Therefore, cells harbor multiple mechanisms of
CO suppression. Arguably most importantly, somatic cells em-
ploy the sister chromatid instead of the homologous chromo-
some in both yeast and mammalian systems to avoid LOH (14,
15). Additionally, as SDSA is inherently refractory to CO for-
mation, it is believed to be the predominant HR subpathway for
the repair of DSBs (16–18). Furthermore, BLM-mediated dis-
solution of dHJs limits COs, with resolution believed to act as a
last resort to handle these intermediates. This is corroborated by
the genomic instability of cells from Bloom’s syndrome patients,
which harbor mutations in BLM and are characterized by sub-
stantially elevated spontaneous levels of sister chromatid ex-
changes (SCEs) (19, 20), a CO outcome of intersister HR events.
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Results from HR reporter systems, where COs are rarely ob-
served, and the lower rate of dHJ formation per DSB in somatic
versus meiotic cells support a general CO-avoidance tendency (5,
15). This notion is also consistent with historic studies suggesting
that DSB-inducing agents, including ionizing radiation (IR), are
poor inducers of SCEs (21, 22). However, it is now known that
most IR-induced two-ended DSBs are repaired in mammalian
cells by nonhomologous end joining (NHEJ) with HR account-
ing for only a fraction of all repair events even in G2 phase,
thereby explaining the relative scarcity of SCEs compared to the
number of induced breaks (23–25). Moreover, the sister chro-
matid represents the natural substrate for HR and COs might
not be readily monitored in reporter systems which rely on un-
equal recombination events between the damaged loci and the
provided substrates. Thus, it is unclear how often COs arise
during HR in somatic cells.
It has been shown that the chromatin remodeler ATRX pro-
motes extended DNA repair synthesis and SCE formation during
HR (26). In this process, ATRX and its partner DAXX deposit
the histone variant H3.3 in a step downstream of RAD51 re-
moval (26). Interestingly, the ATRX/DAXX complex interacts
with the DNA polymerase processivity factor proliferating cell
nuclear antigen (PCNA) after DSB induction, suggesting that
histone deposition is tightly coupled to DNA repair synthesis
(27). Thus, the model emerged that histone deposition at the
D-loop serves to overcome topological constraints arising during
the DNA synthesis step which, if not assuaged, preclude
extended DNA repair synthesis. The observation that SCEs
frequently arise in a manner dependent on ATRX supports
previous findings of high IR-induced SCE frequencies (26, 28). It
further suggests that extended repair synthesis leads to annealing
of the second end to the displaced strand of the D-loop, gen-
erating a JM with the potential for CO formation. This notion is
consistent with findings showing that gene conversion tracts for
CO-forming pathways are substantially larger than for SDSA
(29, 30). However, the frequency of the ATRX subpathway
versus the use of SDSA has not been investigated and would
present an opportunity to quantitatively compare HR subpath-
way choice, but an SDSA-specific factor is required for this
comparison.
Multiple helicases in yeast and mammals have been implicated
to facilitate SDSA, including the yeast Srs2 helicase which is
known to dissociate RAD51 from ssDNA and to promote non-CO
products via SDSA (31–33). Further evidence showed the ability
of Srs2 to dismantle extended D-loops post repair synthesis in a
manner enhanced by small ubiquitin-like modifier (SUMO)-con-
jugated PCNA, thereby allowing strand annealing and CO
avoidance (34). While Srs2 does not have a known homolog in
human cells, multiple helicases have analogous functions. A
prominent example is RECQ5, which has multiple roles in the
DNA damage response. RECQ5 is recruited to sites of DNA
damage in a MRN-dependent manner, resolves replication–
transcription conflicts, and promotes processing of stalled forks
(35–37). Similar to Srs2, RECQ5 has been shown to interact with
A
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Fig. 1. ATRX and RECQ5 define distinct subpathways of HR. (A) U2OSATRX cells, with and without doxycycline-induced ATRX expression, were transfected
with siCtrl or siRECQ5 and treated with RAD51 inhibitor (RAD51i) prior to IR and throughout repair incubation. γH2AX foci were enumerated in EdU-negative
G2 cells. Spontaneous foci (four to six) were subtracted. Knockdown and ATRX expression were confirmed by immunoblotting. Representative images of
γH2AX foci and ATRX expression are shown. (B) U2OS cells were transfected with siCtrl or siRECQ5-2 and GFP, GFP-RECQ5-WT, GFP-RECQ5-ATP, or GFP-RECQ5-
PIP, irradiated and γH2AX foci were enumerated in GFP-positive, EdU-negative G2 cells. Knockdown of the endogenous RECQ5 and GFP-RECQ5 expression
levels were confirmed by immunoblotting (SI Appendix, Fig. S2A). Spontaneous foci (four to six) were subtracted. Representative images of γH2AX foci in GFP-
positive cells are shown. (C) U2OS cells were transfected with GFP, GFP-ATRX-WT, GFP-ATRX-ATP, or GFP-ATRX-PIP, irradiated and γH2AX foci were enu-
merated in GFP-positive, EdU-negative G2 cells. Spontaneous foci (four to six) were subtracted. All data show mean ± SEM (n = 3). Results from individual
experiments, each derived from 40 cells, are indicated. *P < 0.05; **P < 0.01; ***P < 0.001; ns: not significant (two-tailed t test).
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and remove RAD51 from ssDNA using an ATPase activity that is
stimulated by RPA (38, 39). Further studies suggested that this
function serves to promote SDSA by preventing RAD51 filament
reformation post strand displacement that could lead to reinvasion
cycles and increase the chance of JM formation (40). Additionally,
RECQ5 depletion leads to elevated SCE formation, further cor-
roborating its role in promoting SDSA (32, 40).
Here, we show that ATRX and RECQ5 define two distinct
subpathways of HR-mediated repair at two-ended DSBs with
varying individual contributions to overall HR in different cell
lines. We also show that the ATRX-dependent pathway is
dominant over SDSA in cells where both factors are present,
with PCNA interaction being an important node of pathway
choice. A comparison between the number of HR events and the
quantity of IR-induced SCEs reveals that COs are a frequent
outcome of HR. We propose a model in which ATRX-mediated
chromatin remodeling during repair synthesis promotes the
formation of JMs that are dependent on MUS81 and GEN1 for
resolution and are not subject to BLM-mediated dissolution.
This unexpected pathway choice is likely unique to two-ended
DSBs and distinct from HR intermediates generated during S
phase at stalled or collapsed replication forks.
Results
ATRX and RECQ5 Define Distinct Subpathways of HR. The require-
ment for ATRX in HR prompted us to investigate DSB repair in
cells naturally lacking ATRX. Approximately 10 to 15% of all
tumors rely on a telomerase-independent pathway for telomere
elongation, called alternative lengthening of telomeres (ALT).
This ALT phenotype is strongly associated with inactivating
mutations of the ATRX/DAXX/H3.3 complex, with the majority
exhibiting loss of expression of the ATRX protein (41, 42). To
investigate how these cells perform HR, we focused on the
known ALT U2OS cells and used a modified line that expresses
ATRX within the range of physiological levels upon induction
with doxycycline (43) (SI Appendix, Fig. S1A), from herein re-
ferred to as U2OSATRX. To characterize the DSB repair de-
pendency of these cells, we quantified the number of γH2AX
foci as a marker of DSBs and followed their resolution over time
as a measure for DSB repair, as previously described (44). We
specifically analyzed cells irradiated and maintained in G2 phase
during repair to avoid any complications from replication-
associated processes and investigate HR at two-ended DSBs.
Assessment of γH2AX foci in G2-phase U2OSATRX cells
revealed a marked decrease in foci numbers between 2 and 8 h
post IR, indicating efficient repair (Fig. 1A). Inhibition of
RAD51 (RAD51i) resulted in significantly higher levels of
γH2AX foci at 8 h post IR compared to control cells, showing
that U2OSATRX cells perform HR in an ATRX-independent
manner (Fig. 1A). Depletion of the SDSA factor RECQ5 also
resulted in elevated γH2AX foci levels similar to those in
RAD51i-treated cells and inhibition of RAD51 in U2OSATRX
cells lacking RECQ5 did not result in a further increase, indi-
cating that SDSA is used for all HR events (Fig. 1A). Foci levels
at 2 h post IR were not altered after RECQ5 depletion, con-
sistent with previous observations that HR defects are only ob-
servable at later time points while NHEJ repairs DSBs during
the first hours after IR in G2 (23, 24, 26). Expression of ATRX
did not significantly affect γH2AX foci levels in control
U2OSATRX cells at 2 or 8 h but rescued the elevated foci num-
bers at 8 h in RECQ5-depeleted cells, showing that ATRX can
compensate for the loss of RECQ5-mediated SDSA. However,
ATRX expression did not rescue the elevated γH2AX foci level
observed in RAD51i-treated cells, consistent with RAD51 being
upstream of two subpathways of HR defined by the factors
ATRX and RECQ5 (Fig. 1A). A similar result was obtained after
transient ATRX expression in unmodified U2OS cells (SI Ap-
pendix, Fig. S1 B and C) and another ATRX-deficient ALT cell
line, Saos-2 (SI Appendix, Fig. S1D). However, Saos-2 cells
showed higher γH2AX foci levels than U2OS cells that were
reduced after ATRX expression, consistent with lower RECQ5
levels in Saos-2 compared with U2OS cells that might be insuf-
ficient to fully compensate for the lack of ATRX (SI Appendix,
Fig. S1E).
ATRX and RECQ5 Interact with PCNA to Regulate HR Subpathway
Choice. To confirm the specificity of the RECQ5 knockdown
and further characterize the role of RECQ5, we used another
siRNA (siRECQ5-2) and complemented back with siRNA-
resistant GFP-tagged plasmids carrying the wild-type (WT) se-
quence, mutations in the helicase/ATPase domain (RECQ5-
ATP), or mutations in the PCNA-interaction peptide motif
(RECQ5-PIP). U2OS cells treated with siRECQ5-2 and GFP
showed an elevated level of γH2AX foci 8 h after IR which was
rescued by the expression of siRNA-resistant RECQ5-WT,
confirming the specificity of the knockdown (Fig. 1B and SI
Appendix, Fig. S2A). Interestingly, both RECQ5-ATP and
RECQ5-PIP failed to rescue the repair defect, showing that both
domains are important for RECQ5 function in HR (Fig. 1B). In
contrast to the helicase/ATPase function, the requirement of the
PIP domain was unexpected and raised the possibility that both
RECQ5 and ATRX are competing for PCNA binding, as ATRX
has been already shown to require its PIP domain for HR (26).
To explore this possibility, we overexpressed ATRX defective
for either its ATPase function (ATRX-ATP) or its PCNA in-
teraction (ATRX-PIP) in U2OS cells lacking ATRX and asked if
they differentially interfere with subpathway choice. We have
previously shown that both mutants are defective in the ATRX
pathway as they fail to restore repair in HeLa ATRX KO cells,
assessed by γH2AX foci analysis and the formation of BrdU
repair foci (26). Moreover, the ATRX-PIP but not the ATRX-
ATPase mutant fails to interact with PCNA in coimmunopreci-
pitation (co-IP) studies (26). Of note, the ATRX-PIP mutant did
not affect foci levels in U2OS cells (Fig. 1C), indicating that
repair could still take place. In contrast, ATRX-ATP caused a
repair defect, presumably by outcompeting RECQ5-dependent
SDSA through PCNA binding but failing to complete repair due
to defective ATPase function (Fig. 1C). Control experiments
confirmed that neither ATRX-PIP nor ATRX-ATP is able to
rescue the repair defect in siRECQ5-treated U2OS cells (SI
Appendix, Fig. S2B). These data suggest that HR subpathway
usage is governed by the ability of both ATRX and RECQ5 to
interact with PCNA.
ATRX and RECQ5 Differentially Affect Long Tract Gene Conversion
and SCE Formation. Since extended DNA repair synthesis is a
key feature of ATRX-dependent HR, we assessed how RECQ5
affects this step using our previously described BrdU incorpo-
ration assay (23, 26). Cells were irradiated and maintained in G2
phase during repair, and the incorporation of the nucleoside
analog BrdU at DSB sites was quantified by enumerating visible
BrdU foci. Robust BrdU foci formation at 8 h post IR was ob-
served only in ATRX-expressing U2OSATRX cells (Fig. 2A).
Depletion of RECQ5, in contrast to the lack of ATRX, slightly
increased BrdU foci formation (Fig. 2A). These results show that
extended DNA repair synthesis is strictly dependent on ATRX
which outcompetes RECQ5-dependent SDSA, as most BrdU
foci are not suppressed by RECQ5.
We additionally investigated the distinct roles of ATRX and
RECQ5 during DNA repair synthesis by using a reporter assay
that discriminates between short (STGC) and long tract gene
conversion (LTGC) events (45). Expression of the I-SceI nu-
clease leads to a DSB in a GFP gene that can be repaired using a
GFP donor sequence positioned 5′ of the acceptor gene as a
template for repair (Fig. 2B). The specific feature of this assay is
its ability to monitor the extent of DNA repair synthesis that
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leads to restoration of the GFP gene. During STGC, DSB repair
proceeds by limited DNA repair synthesis while LTGC involves
copying a cassette that was inserted between the two GFP genes,
leading to the duplication of this cassette and expression of an
antibiotic resistance gene (Fig. 2B). Hence, LTGC confers an-
tibiotic resistance in addition to GFP expression while STGC
involves GFP expression but no antibiotic resistance. To assess
the roles of RECQ5 and ATRX in STGC and LTGC, we
expressed ATRX in U2OS cells carrying this reporter cassette.
Compared to such cells with both factors present, U2OS cells
without ATRX showed substantially reduced LTGC (26)
(Fig. 2C). In contrast, depletion of RECQ5 in U2OS cells with or
without ATRX nearly abolished STGC (Fig. 2C). These results
reveal that RECQ5-dependent HR involves short patches of
DNA repair synthesis while ATRX-dependent HR proceeds by
extended DNA repair synthesis. A comparison with the BrdU
incorporation assay suggests that a fraction of the LTGC events
assessed in the reporter assay can give rise to microscopically
visible BrdU foci while STGC does not. The presence of basal
LTGC events in cells lacking ATRX and/or RECQ5 could be the
result of an alternative pathway, possibly BIR at one-ended
breaks arising when cells replicate.
To further dissect how the subpathways interact, we analyzed
SCEs arising in response to G2-induced damage as a known out-
come of the ATRX pathway (26). We optimized the time used for
SCE measurement for U2OSATRX cells based on their cell cycle
progression (SI Appendix, Fig. S2C) and confirmed their DSB repair
capacity for the corresponding repair time (SI Appendix, Fig. S2D).
We observed IR-induced SCEs only in ATRX-expressing
U2OSATRX cells and RECQ5 depletion in those cells caused only
modestly higher levels, supporting the notion that the ATRX sub-
pathway dominates over RECQ5-dependent SDSA (Fig. 2D).
HR Subpathway Usage in ATRX-Proficient Cancer and Normal Cells. To
investigate if similar subpathway usage occurs in other cell types,
we then carried out similar repair analyses in ATRX-proficient
A B C
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Fig. 2. ATRX and RECQ5 differentially affect long tract gene conversion and SCE formation. (A) U2OSATRX cells, with and without doxycycline-induced ATRX
expression and transfected with siCtrl or siRECQ5, were labeled with EdU, irradiated, and then incubated with BrdU for 8 h. BrdU foci representing DNA repair
synthesis were enumerated in EdU-negative G2 cells. Spontaneous foci (fewer than one) were subtracted. (B) Schematic diagram of the LTGC/STGC reporter
system. U2OS cells carry a 5′ truncated GFP cassette followed by two incorrectly oriented exons (exon B placed 5′ to exon A) of the Blasticidin resistance (BsdR)
gene, and a GFP cassette that is disrupted by the recognition sequence of the I-SceI endonuclease. To obtain a functional GFP protein, the break has to be repaired
by HR using the truncated GFP cassette as a template. STGC events of fewer than 1 kbp result in a functional GFP gene but fail to correctly orient the exons of the
BsdR gene, and the cells are thus sensitive to Blasticidin. LTGC events of >1 kbp restore the GFP sequence and additionally place exon B of the BsdR gene 3′ to
exon A, reinstating correct orientation and conferring Blasticidin resistance. Thus, LTGC events lead to GFP+, BsdR+ cells [imagemodified from Nagaraju et al. (45)].
For the analysis, GFP+ cells (representing both STGC and LTGC events) and BsdR+ cells (LTGC events) are enumerated. (C) U2OS STGC/LTGC reporter cells were
transfected with siCtrl or siRECQ5 and pUC19 or myc-ATRX and 40 h later transfected with I-SceI plasmids. Cells were assessed for GFP expression and Blasticidin
resistance and numbers were plotted as a fraction of all cells. Control experiments showed that the fraction of S/G2-phase cells varied by less than 5% between
siRECQ5-treated, ATRX-expressing, and control cells, excluding that changes in cell cycle distributions substantially influence the results. Knockdown was con-
firmed by immunoblotting and myc-ATRX expression efficiency was previously assessed (26). The significance indication above the white bar compares the LTGC
fraction of pUC19 to the ATRX-expressing siCtrl-treated cells; indications above the black bars compare STGC fractions upon RECQ5 depletion to the respective
siCtrl-treated cells. (D) U2OSATRX cells, with and without doxycycline-induced ATRX expression, were transfected with siCtrl or siRECQ5 and incubated with BrdU
for 48 h. Cells were then irradiated with 2 Gy, collected after 16 h, and processed to obtain mitotic spreads. SCEs per spread were quantified and normalized to 70
chromosomes. Representative images of chromosome spreads of nonirradiated and irradiated siCtrl-treated cells with and without ATRX expression are shown;
red arrows in the magnifications show individual SCE events. Data inA and C showmean ± SEM (n = 3). Results from individual experiments, each derived from 40
cells in A, are indicated. Individual SCE data are shown and red horizontal lines indicate the mean; 70 to 120 spreads and >4,000 chromosomes per condition were
analyzed from three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns: not significant (two-tailed t test); NIR: nonirradiated.
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HeLa WT cells where, unlike U2OS cells, RECQ5 depletion
conferred only a mild DSB repair defect at 8 h after IR (Fig.
3A). In contrast, HeLa ATRX knockout (KO) cells showed
substantially elevated foci numbers as previously described
(26). RECQ5 depletion in ATRX KO cells led to unrepaired
DSBs similar to inhibition of RAD51, consistent with ATRX-
and RECQ5-dependent HR accounting for the majority of all
IR-induced HR events (Fig. 3A). Interestingly, HeLa cells
overexpressing RECQ5-ATP but not RECQ5-WT or RECQ5-
PIP exhibited partially elevated foci numbers at 8 h post IR
(SI Appendix, Fig. S3A), confirming that PCNA interaction is
central to HR subpathway choice. We also analyzed SCE for-
mation and repair synthesis and, similar to U2OS cells, ob-
served IR-induced SCEs and BrdU foci only in ATRX-
expressing cells where RECQ5 depletion led to only a modest
increase in SCE and BrdU foci numbers (Fig. 3B and SI Ap-
pendix, Fig. S3B). Taken together, these data show that HeLa
cells rely primarily on ATRX for the repair of DSBs in G2 even
in the presence of RECQ5.
Since cancer cells utilize the RECQ5 pathway to different
extents, we next asked how normal, untransformed cells mediate
HR subpathway choice. We investigated hTert-immortalized
primary human fibroblasts (82-6 cells) and observed elevated
γH2AX foci numbers at 8 h after IR following depletion of
ATRX while siRECQ5 did not affect foci numbers with or
without ATRX depletion (Fig. 3C). RAD51i led to similarly
elevated foci numbers as ATRX depletion and siATRX and/or
siRECQ5 did not further increase foci numbers in RAD51i-
treated cells (Fig. 3C). Additionally, we observed IR-induced
SCE formation and BrdU foci whose levels remained un-
changed in RECQ5-depleted cells but was abolished by ATRX
depletion (Fig. 3D and SI Appendix, Fig. S3 C and D). Thus,
unlike U2OS and HeLa cells, normal cells seem to exclusively
utilize the ATRX pathway with no apparent contribution of
RECQ5-dependent SDSA.
HR and SCE Frequencies at IR-Induced DSBs. A more quantitative
comparison between the number of HR events promoted by the
ATRX subpathway and the consequent formation of COs was
A B
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Fig. 3. HR subpathway usage in ATRX-proficient cancer and normal cells. (A) HeLa WT and ATRX KO cells were transfected with siCtrl or siRECQ5 and treated
with RAD51i prior to IR and throughout repair incubation. γH2AX foci were enumerated in EdU-negative G2 cells. Spontaneous foci (three to four) were
subtracted. Knockdown was confirmed by immunoblotting. Data for siCtrl were extracted from supplemental appendix, figure S3A in ref. 26 as they were
part of the same experiment with siRECQ5. (B) HeLa WT and ATRX KO cells were transfected with siCtrl or siRECQ5 and incubated with BrdU for 48 h. Cells
were then irradiated with 2 Gy, collected after 8 h, and processed to obtain mitotic spreads. SCEs per spread were quantified and normalized to 70 chro-
mosomes. (C) 82-6 cells were transfected with siCtrl, siRECQ5, and/or siATRX and treated with RAD51i prior to IR and throughout repair incubation. γH2AX
foci were enumerated in EdU-negative G2 cells. Spontaneous foci (one to two) were subtracted. Knockdown was confirmed by immunoblotting. (D) 82-6 cells
were transfected with siCtrl, siRECQ5, and/or siATRX and incubated with BrdU for 48 h. Cells were then irradiated with 2 Gy, collected after 12 h, and
processed to obtain mitotic spreads. SCEs per spread were quantified and normalized to 46 chromosomes. Foci data show mean ± SEM (n = 3). Results from
individual experiments, each derived from 40 cells, are indicated. Individual SCE data are shown and red horizontal lines indicate the mean; 70 to 120 spreads
and >4,000 chromosomes per condition were analyzed from three independent experiments. *P < 0.05; **P < 0.01; ***P < 0.001; ns: not significant
(two-tailed t test).
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carried out using RAD51 foci as a specific marker for HR. Total
HR events in ATRX-proficient U2OSATRX, HeLa, and 82-6 cells
were estimated to be the net difference between the peak
number of RAD51 foci formed and the residual foci level at the
end of the repair time used for the SCE measurements. All three
cell lines showed similar numbers of RAD51 foci being maxi-
mally formed (SI Appendix, Fig. S4A) and had a near-identical
number of net HR events irrespective of RECQ5 presence (∼20)
(SI Appendix, Fig. S4B). These 20 HR events led to about 8 SCEs
above background level, which increase in U2OSATRX and HeLa
cells upon RECQ5 depletion to about 10 IR-induced SCEs (Figs.
2D and 3 B and D).
We also addressed some of the potential limitations of our
SCE and repair assays. First, we confirmed previous data that no
substantial RAD51 foci loss occurred until the peak time by
depleting RAD54, a factor known to remove RAD51 (3, 26) (SI
Appendix, Fig. S5A). We additionally confirmed the total number
of HR events by assessing the accumulation of the phosphory-
lated form of the replication protein A, a marker for resected
DSBs (SI Appendix, Fig. S5B). Further, while a dose of 2 Gy can
be considered nonphysiological, we show a similar ATRX de-
pendency and SCE frequency at lower doses (SI Appendix, Fig.
S5 C and D). It is worth noting in this context that depleting
RECQ5 mildly elevates spontaneous SCEs, consistent with
RECQ5’s role in resolving replication–transcription conflicts
(37), but to a level substantially lower than those induced by 2
Gy. Thus, the analysis of SCEs induced by 2 Gy is less likely to be
affected by a small change in spontaneous breaks than analyses
at lower doses. Additionally, BrdU-labeled cells used for the
SCE assay show similar HR usage as non-BrdU-substituted cells
(SI Appendix, Fig. S5E).
ATRX-Dependent HR Leads to the Formation of IR-Induced
MUS81-Dependent Intermediates. The high SCE frequency ob-
served in the ATRX subpathway suggested a strong reliance on
nuclease-dependent resolution of JMs formed after the com-
pletion of DNA synthesis. To further characterize this pathway,
the formation of HR intermediates in response to IR was ana-
lyzed. Several types of JMs can be visualized in anaphase/telo-
phase cells as DAPI-negative ultrafine bridges (UFBs) that
immunostain positively for RPA and/or BLM (46, 47). Recently,
HR-specific intermediates were shown to arise in cells depleted
of MUS81 and GEN1, and increase following DNA damage that
is repaired by HR (48). To assess if such intermediates also arise
in response to IR, HeLa and U2OS cells were transfected with
siMUS81 and siGEN1, irradiated with 4 Gy, and analyzed for
UFB formation (Fig. 4A). We chose these two cell systems be-
cause their good proliferation allowed the most reliable assess-
ment of mitotic cells in this assay. EdU was added to the cells
before IR and only EdU-negative anaphase cells were analyzed
to ensure the observed UFBs are specific to HR events in G2.
HeLa cells treated with siCtrl exhibited a modest but nonsig-
nificant increase in UFBs 8 h post IR (Fig. 4A). Consistent with
published data, unirradiated nuclease-depleted HeLa and U2OS
cells showed an increase in UFBs compared to unirradiated
siCtrl-treated cells, likely arising from S phase-generated joint
structures that were carried over to G2 (48). However, irradiated
nuclease-depleted HeLa cells exhibited approximately a fourfold
increase in UFBs, demonstrating that IR-induced JMs are pro-
cessed by nucleases that can give rise to CO products (Fig. 4A).
In contrast, U2OS cells failed to show such an IR-induced in-
crease in nuclease-depleted cells, indicating that IR-induced
UFBs specifically arise in cells utilizing the ATRX subpathway
(Fig. 4A). We also analyzed UFB staining patterns and found
that most bridges in nuclease-depleted samples stained for RPA
only or RPA plus BLM and only a small fraction was positive for
BLM only. No considerable differences in staining patterns were
observed between nonirradiated and irradiated as well as be-
tween HeLa and U2OS cells (SI Appendix, Fig. S6A).
After establishing a role for MUS81 in resolving these HR
structures arising in G2-irradiated cells, MUS81 localization to
DSBs in response to IR was also analyzed. HeLa and U2OS cells
were assessed for the recruitment of MUS81 to γH2AX foci 8 h
after IR. Since discrete MUS81 foci were difficult to visualize in
G2, cells in prophase were analyzed, consistent with a peak of
MUS81 nuclear localization at G2/M entry (6). HeLa cells
exhibited a significant increase in MUS81 foci in response to IR,
with ∼60% colocalizing with γH2AX foci (Fig. 4B). In contrast,
U2OS cells did not show an IR-induced elevation of MUS81 foci
levels, despite having significantly more foci than unirradiated
HeLa cells. Furthermore, most MUS81 foci in both irradiated
and unirradiated U2OS samples did not colocalize with γH2AX
foci, indicating their recruitment to structures other than DSB-
derived intermediates, likely 3′ flaps or other structures from
replication-associated events (Fig. 4B).
Processing of ATRX-Dependent HR Intermediates Is BLM Independent.
Since HR intermediates can also be targeted by dissolution that
prevents COs, the involvement of this pathway was investigated
by depleting the BLM helicase. Since BLM has been reported to
also be involved in resection (49), the proficiency of HR was first
assessed in BLM-depleted cells. HeLa and U2OS cells treated
with siBLM showed normal peak formation of RAD51 foci at 2 h
post IR and similar γH2AX foci levels at 2 and 8 h compared to
control cells, confirming that resection in G2 is unaffected and
that repair can take place via HR (Fig. 5A). Since BLM was
shown to unwind double-stranded DNA (dsDNA) at UFBs,
allowing for RPA binding, BLM deficiency prevents UFB visu-
alization using BLM or RPA immunofluorescence (48). There-
fore, this assay could not be used for the analysis of HR
intermediate formation. Instead, MUS81 foci formation was
assessed in the absence of BLM, with increased levels expected
to compensate for loss of the BLM function under investigation.
MUS81 foci were enumerated in prophase, prometaphase, and
metaphase cells 8 h post 2 Gy in both HeLa and U2OS cells.
Consistent with data described above, HeLa cells exhibited a
significant IR-induced increase in MUS81 foci in all mitotic
stages, with the highest foci numbers in prophase (Fig. 5B) and
reduced numbers in prometaphase and metaphase cells (SI Ap-
pendix, Fig. S6B). BLM depletion did not impact MUS81 foci
levels in any of the mitotic stages analyzed, suggesting that the
resolvase already occupies all cleavable structures even in the
presence of BLM (Fig. 5B and SI Appendix, Fig. S6B). U2OS
cells had similar numbers of MUS81 foci in both unirradiated
and irradiated samples in all mitotic stages, which also decreased
from prophase to metaphase. Depletion of BLM slightly de-
creased MUS81 foci in prophase cells, after which they stayed
similar to control levels in prometaphase and metaphase cells
(Fig. 5B and SI Appendix, Fig. S6B). Therefore, in both cell lines,
BLM depletion did not increase MUS81 foci localization, sug-
gesting that it does not enhance the level of resolvase-positive
JM structures.
We also assessed SCE formation to test if the knockdown of
BLM would lead to more IR-induced exchanges, as the unpro-
cessed structures would then be resolved by nucleases. Consis-
tent with the literature, BLM depletion significantly increased
SCE levels in unirradiated cells, which are known to be caused by
the resolution of intermediates arising during S phase that are
normally dissolved by the BTR complex (6, 50) (Fig. 5C). BLM-
depleted cells also exhibited an increase in SCEs in response to
IR, but to an extent similar to BLM-proficient cells (Fig. 5C),
indicating that BLM normally does not process HR intermedi-
ates arising from two-ended DSBs.
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HR by ATRX and RECQ5. HR of two-ended DSBs can proceed by
SDSA or a pathway involving JM formation. Key distinguishing
features between the two pathways are the extent of DNA repair
synthesis and potential for CO formation. SDSA is believed to
involve only limited DNA repair synthesis prior to strand dis-
placement and annealing to the second, noninvasive break end,
thus preventing CO formation. In contrast, following extended
repair synthesis, the noninvading end can anneal to the D-loop
which leads to the formation of a JM with the potential for CO
formation. RECQ5 has previously been implicated in SDSA (40)
while ATRX has been shown to promote extended DNA repair
synthesis and SCE formation (26). Here, we present evidence
that RECQ5 and ATRX define distinct RAD51-dependent HR
subpathways which together account for the majority, if not all,
of HR events at two-ended DSBs. The analysis of RECQ5 mu-
tants revealed that its helicase/ATPase function is essential for
SDSA, as previously suggested (40). Interestingly, the ability to
interact with PCNA is also important for DSB repair, suggesting
that RECQ5 functions during or after DNA synthesis. Interac-
tion with PCNA also likely serves as a node of regulation be-
tween the subpathways to define the level at which RECQ5 and
ATRX compete for DSB repair (Fig. 6).
We argue that the ATRX-dependent pathway outcompetes
SDSA in cells where both pathways are present based on mul-
tiple observations. First, loss of ATRX in HeLa cells causes a
greater repair defect than loss of RECQ5 and siATRX in 82-6
cells causes a repair defect similar to RAD51 inhibition while
siRECQ5 has no effect. Additionally, HeLa, U2OSATRX and 82-
6 cells expressing ATRX show BrdU foci and SCE levels that are
only slightly or not at all increased after siRECQ5. Since ATRX-
dependent HR has the potential to form COs, these observations
challenge the widely held belief that CO formation is suppressed
in mammalian cells. Indeed, we discuss below that HR involving
ATRX-dependent extended repair synthesis frequently leads
to SCEs.
It is important to note that U2OS and to a lesser extent Saos-2
and HeLa cells require SDSA while nontransformed cells do not
use RECQ5 for the repair of IR-induced DSBs. This highlights
the discrepancy between cell lines in their HR subpathway usage,
an aspect that should be taken into consideration when analyzing
repair assays and warrants further investigation into how sub-
pathway choice is made. This is also relevant when studying the
ALT process in ATRX-deficient cells, which rely on an HR
subpathway for telomere maintenance and whose differences in
the repair of internal breaks might be paralleled at the
telomeres (51).
SCEs Frequently Arise in Irradiated Mammalian Cells. Here, we
quantitatively compare the number of RAD51-dependent HR
events in irradiated HeLa, U2OS, and 82-6 cells with the number
of induced SCEs, all measured at the same condition. Our
γH2AX and RAD51 foci analyses after a dose of 2 Gy reveal ∼20
HR events in HeLa and U2OS cells that give rise to about 10
SCEs. The estimate of 20 HR events is consistent with our
previous studies showing that a dose of 2 Gy induces ∼100 DSBs
A
B
Fig. 4. ATRX-dependent HR leads to the formation of IR-induced MUS81-dependent HR intermediates. (A) HeLa and U2OS cells were transfected twice on
consecutive days with siCtrl or siMUS81+siGEN1, irradiated, and RPA- and/or BLM-positive UFBs were enumerated in EdU-negative late anaphase cells.
Representative images of UFBs in MUS81- and GEN1-depleted HeLa and U2OS cells are shown. Knockdown was confirmed by immunoblotting. (B) HeLa and
U2OS cells were irradiated with 2 Gy, prophase cells positive for the mitotic marker pH3 and negative for EdU were selected, and Z-stack images were
captured and analyzed for MUS81 foci numbers and colocalization with γH2AX foci. All data show mean ± SEM (n = 3) and results from individual exper-
iments, each derived from 40 (A) or 20 (B) cells, are indicated. **P < 0.01; ***P < 0.001; ns: not significant (two-tailed t test); NIR: nonirradiated.
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per G2 cell of which 20% undergo repair by HR (23, 24). Also
the analysis of 82-6 cells showed robust formation of IR-induced
SCEs, although slightly less frequently as in HeLa and U2OS
cells. Nevertheless, this demonstrates that the pronounced pro-
pensity to employ a CO-forming pathway is not a peculiarity of
cancer cells. However, SCE formation is strictly dependent on
ATRX as it is not observed in HeLa ATRX KO cells, in U2OS
cells without ATRX induction or in 82-6 cells after ATRX de-
pletion. Collectively, these data suggest that approximately every
second ATRX-dependent HR event leads to an SCE, a consid-
erably higher frequency than previously thought, while RECQ5-
dependent SDSA does not form SCEs, a notion consistent with
published data (40). The most likely explanation for this obser-
vation is that ATRX promotes extended DNA repair synthesis
which leads to second-end capture and the formation of a JM
with a 50% likelihood to be resolved into an SCE. Thus, we
argue that CO formation is a frequent event in mammalian cells
but necessitates the presence of ATRX. It is, therefore, not
readily detected in ALT cells (e.g., U2OS cells) which are often
used for cellular studies. Additionally, HR reporter assays typi-
cally rely on the analysis of unequal recombination events be-
tween the damaged loci and the provided substrates which might
skew HR subpathway choice. Since the sister chromatid repre-
sents the natural substrate for HR events, we argue that SCE
measurements more reliably assess CO frequencies.
ATRX-Dependent HR Intermediates Are Exclusively Channeled into
the Resolution Pathway. Our analysis raises the question about
the primary pathway used to deal with the ATRX-dependent HR
intermediates and suggests that resolution strongly outcompetes
dissolution. We explored this idea by analyzing the formation of
HR intermediates in the ATRX pathway and found that
resolvase-deficient cells accumulate IR-induced UFBs, which are
not observed in ATRX-deficient cells. Additionally, the IR-
induced recruitment of MUS81 to DSBs was only observed in
ATRX-expressing cells and was not suppressed by BLM, further
corroborating the notion that the MUS81 and GEN1 resolvases
play a major role in processing the HR intermediates formed by
the ATRX subpathway (Fig. 6). Moreover, the SCE assay
showed no increase in IR-induced SCEs in the absence of BLM,
precluding its function in processing these HR intermediates. Of
note, in contrast to IR-induced SCEs, the level of spontaneous
SCEs increases drastically upon BLM depletion, suggesting that
they arise from different substrates, such as dHJs formed at
single-stranded gaps or template switches after fork regression,
that are specifically handled by the BTR complex (11, 52). The
choice between resolution and dissolution pathways could also
be influenced by the position in the cell cycle, as the MUS81-
EME1 nuclease activity peaks during late G2/M, while the BTR
complex is not known to be restricted to a specific cell cycle
phase (8). Thus, we cannot rule out that the temporal regulation
of the nucleases might affect the differential processing of HR
A B
C
Fig. 5. Processing of ATRX-dependent HR intermediates is BLM independent. (A) HeLa and U2OS cells were transfected with siCtrl or siBLM, irradiated, and
γH2AX (Left) and RAD51 (Right) foci were enumerated in EdU-negative G2 cells. Spontaneous foci (four to six γH2AX and fewer than one RAD51) were
subtracted. Knockdown was confirmed by immunoblotting. (B) HeLa and U2OS cells were transfected with siCtrl or siBLM, irradiated with 2 Gy, and MUS81
foci were enumerated in pH3-positive, EdU-negative prophase cells. (C) HeLa cells were transfected with siCtrl or siBLM and incubated with BrdU for 48 h.
Cells were then irradiated with 2 Gy, collected after 8 h, and processed to obtain mitotic spreads. SCEs per spread were quantified and normalized to 70
chromosomes. Bar graph shows the IR-induced SCE numbers (total SCEs after background subtraction). Representative images of chromosome spreads from
unirradiated siCtrl- and siBLM-treated cells are shown on the right; red arrows in the magnifications show individual SCE events. Individual SCE data are
shown and red horizontal lines indicate the mean; 70 to 120 spreads and >4,000 chromosomes per condition were analyzed from three independent ex-
periments. Foci and IR-induced SCE data show mean ± SEM (n = 3) and results from individual experiments, each derived from 40 (A and C) or 20 (B) cells, are
indicated. *P < 0.05; **P < 0.01; ***P < 0.001; ns: not significant (two-tailed t test); NIR: nonirradiated.
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intermediates induced by IR in G2 or arising in S phase at the
replication fork.
Notwithstanding such possibilities, our findings suggest the
formation of a distinct HR intermediate by the ATRX pathway.
One possibility is the formation of a dHJ that is structurally
distinct and is resistant to dissolution by BLM, which could also
be explained in light of the chromatin-remodeling function of
ATRX. Histone deposition within the D-loop could “chromati-
nize” the dsDNA regions consisting of the two single strands
from both sister chromatids and physically impede strand sepa-
ration and counteract helicase function, suppressing both
RECQ5 and BLM (SI Appendix, Fig. S7A). This is reminiscent of
the antagonistic effect of the chromatin remodeler CAF-1 on the
RecQ-type helicase Rqh1 during repair synthesis observed in
fission yeast, where chromatin assembly on the D-loop coun-
teracts strand displacement and favors D-loop stability (53, 54).
Therefore, ATRX’s function in D-loop stabilization and repair
synthesis promotion through histone deposition and RECQ5
suppression could have the secondary effect of counteracting
BLM function, resulting in a high CO frequency. Alternatively,
the apparent lack of BLM processing of these intermediates
raises the intriguing possibility of the HR intermediates arising
during DSB repair being distinct from the classical dHJ struc-
ture, such as nicked HJs, D-loops, or other substrates that are
more suitable for resolution reactions (SI Appendix, Fig. S7 B
and C).
Conclusion
The data presented here show ATRX and RECQ5 define two
distinct HR subpathways for repairing DSBs, with ATRX being
essential for a CO-forming pathway and RECQ5 promoting
SDSA. A quantitative comparison between the relative usages of
the two subpathways suggests that ATRX outcompetes RECQ5
for the majority of HR events, likely through PCNA interaction,
and leads to the formation of COs in approximately half of these
events. The more extended DNA repair synthesis promoted by
ATRX likely results in second-end capture and the formation of
HR intermediates that are exclusively processed by resolvases
and are not subject to dissolution by BLM, therefore constituting
distinct substrates from those formed spontaneously during S
phase. Our work highlights a potential role for chromatin
remodeling in determining HR subpathway choice and the for-
mation of intermediates that are distinct from the classical
dHJ. Our model questions the current belief that CO formation
is largely suppressed in mammalian cells and warrants recon-
sideration of studies which addressed the question of HR sub-
pathway usage by investigating ATRX-deficient cell lines or
artificial substrates for HR.
Materials and Methods
Cell Lines and Cell Culture. HeLa-S3 WT (ATCC), HeLa ATRX KO, and U2OS
(ATCC) cells were cultured in Dulbecco’s Modified Eagle’s Medium (DMEM,
Sigma) supplemented with 10% fetal calf serum (FCS) and 1% nonessential
amino acids (NEAA). Saos-2 (ATCC) cells were cultured in McCoy’s 5A with
15% FCS. U2OS ST/LT GC reporter cells were kindly provided by Ralph Scully,
Harvard Medical School, Boston, MA (45) and were cultured in DMEM con-
taining the aforementioned supplements plus 2 mg/mL puromycin.
U2OSATRX cells with inducible ATRX expression were a gift from David
Clynes, University of Oxford, Oxford, United Kingdom (43) and were grown
in DMEM with 10% tetracycline-free fetal bovine serum, 700 μg/mL G418
sulfate, 0.5 μg/mL puromycin, and 1× glutamate. Immortalized human pri-
mary fibroblasts (82-6 hTert cells) were a gift from Robert Schiestl, University
of California, Los Angeles, CA, and cultured in Minimum Essential Medium
supplemented with 20% FCS and 1% NEAA. Cells were routinely tested for
mycoplasma contamination by PCR (Minerva Biolabs). All cell lines were
maintained at 37 °C in a 5% CO2 incubator.
RNA Interference, Plasmid Transfection, and Inhibitors. Transfection of cells
with siCtrl (5′-AAT TCT CCG AAC GTG TCA CGT-3′), siRECQ5 (Dharmacon
smart pool, E-019338-00-0010), siRAD51 (target sequence: 5′-AAG GGA ATT
AGT GAA GCC AAA-3′), siRECQ5-2 (5′-GGA GAG TGC GAC CAT GGC T-3′),
siATRX (5′-GAG GAA ACC TTC AAT TGT ATT-3′), siMUS81 (5′-AAC AGC CCT
GGT GGA TCG ATA-3′), siGEN1 (5′-AAG CGT AAT CTT GGT GGG AAA-3′),
siBLM (5′-AAG CTA GGA GTC TGC GTG CGA-3′), siRAD54 (5′-GAA CTC CCA
TCC AGA ATG ATT-3′) and siBRCA2 (5′-TTG GAG GAA TAT CGT AGG TAA-3′)
was carried out using Lipofectamine RNAiMAX (Thermo Fisher) according to
the manufacturer’s instructions. Experiments were performed 48 or 72 h
after transfection. For plasmids, GFP-ATRX (Addgene, 45444), myc-ATRX
(Origene, RC215176), GFP-ATRX-WT, GFP-ATRX-ATP, GFP-ATRX-PIP, pEGFP
(Clontech, 632470), GFP-RECQ5-WT, GFP-RECQ5-ATP, GFP-RECQ5-PIP, pUC19
(New England Biolabs, N3041S) and pBL464_pCBASceI were transfected us-
ing Lipofectamine LTX or PEI (Sigma) according to the manufacturer’s in-
structions. The ATRX mutant constructs were previously described (26) and
the RECQ5 mutant constructs were kindly provided by Pavel Janscak, Uni-
versity of Zurich, Zurich, Switzerland (37). For chemical inhibition of RAD51,
cells were treated with 60 μM B02 (Calbiochem) 30 min prior to IR and the
inhibitor was maintained throughout repair incubation.
Irradiation and Cell Cycle-Specific DSB Repair Analysis. Irradiation was per-
formed with an X-ray machine operated at 90 kV and 19 mA with an alu-
minum filter. For cell cycle-specific analysis of DSB repair, the thymidine
analog EdU (10 mM, Baseclick, BCN-001) was added to asynchronously
growing cells 30 min prior to IR and maintained throughout the repair in-
cubation period. After fixation and immunostaining, DAPI and EdU inten-
sities were measured and plotted in a diagram using a Zeiss microscope and
MetaCyte software (Metasystems). EdU-positive cells were identified as
S-phase cells, while the EdU-negative cells were categorized as either G1 or
G2 based on their DNA content. Cells transitioning from G1 to S and G2
phase incorporated EdU, thus assessed as S-phase cells, and were conse-
quently excluded from analysis.
Immunofluorescence. Cells grown on glass coverslips were fixed with 3%
formaldehyde in phosphate-buffered saline (PBS) for 10 min at room tem-
perature (RT). After washing three times with PBS, cells were permeabilized
with 0.5% Triton X-100 in PBS for 10 min at 4 °C, and washed and blocked
for 0.5 to 1 h at RT with 1× Rotiblock (Roth). For mitotic cell analyses, cells
Fig. 6. Model for the interplay between ATRX and RECQ5 to regulate dis-
tinct subpathways of HR. Repair of two-ended DSBs by ATRX-mediated HR
outcompetes RECQ5, possibly through PCNA binding, thereby suppressing
SDSA. Upon the completion of DNA repair synthesis, the resulting JM is not
subject to dissolution by BLM and is channelled into the resolution pathway
by MUS81 and GEN1, leading to equal probability of CO and non-
CO products.
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were fixed with PTEMF buffer (20 mM Pipes pH 6.8, 0.2% Triton X-100,
10 mM ethylene glycol tetraacetic acid, 1 mM MgCl2 and 4% formaldehyde)
for 10 min and then permeabilized with 0.2% Triton X-100 in PBS for 5 min.
Antibodies against γH2AX (rabbit Abcam, ab81299, mouse Millipore, 05-636,
chicken Biozol, BRD-0675MZ), RAD51 (Abcam, ab63801), MUS81 (Santa Cruz,
sc-53382), RPA32 (Abcam, ab2175), BLM (Santa Cruz, sc-7790), pH3 (Milli-
pore, 06-570), BrdU (BD Pharmingen, 555627), ATRX (Santa Cruz, sc-15408),
GFP (Roche, 11 814 460 001), and RPA32/RPA2 (p-T21) (Abcam, ab109394),
were added overnight at 4 °C and EdU was stained using the EdU Click-iT Kit
(Roth) according to the manufacturer’s instructions. After secondary anti-
body incubation, cells were washed and stained with DAPI (0.4 mg/mL) for
10 min at RT and then embedded with Vectashield mounting medium
(Vector Laboratories). Cells were examined using a Zeiss microscope and cell
cycle-specific analysis was carried out by the manual enumeration of foci in
G2 cells (23).
Site-Directed Mutagenesis. Constructs encoding GFP-RECQ5-WT, GFP-RECQ5-
ATP, and GFP-RECQ5-PIP were subjected to site-directed mutagenesis to
introduce three silent mutations to confer resistance to siRECQ5-2 using the
primers Fwd: 5′-CGCCTTTACAGGAGAGCGCTACGATGGCTGTAGTAAAAGG-3′
and Rev: 5′-CCTTTTACTACAGCCATCGTAGCGCTCTCCTGTAAAGGCG-3′. The
mutagenesis reaction was carried out using Q5 high-fidelity polymerase
(NEB) and the product was treated with DpnI to degrade the methylated
parent plasmid followed by transformation into competent Dh5α Escherichia
coli cells. Single colonies were picked after kanamycin selection, expanded,
and plasmid DNA was extracted using the ZR plasmid miniprep kit
(ZymoResearch) or for higher yield, peqGOLD Xchange plasmid maxi-EF kit
(Peqlab). The insertion of the mutations was confirmed by sequencing
(Microsynth) using the sequencing primer 5′-GAGCAGCCACCATACCAC CT-3′.
Reporter Assay.U2OS ST/LT GC reporter cells were transfectedwithmyc-ATRX
or pUC19 plasmids and/or siRNA and 40 h later, transfected with I-SceI
plasmids. Cells were collected after 48 h and for each sample, a fraction of
cells was fixed and another was seeded in defined numbers into Petri dishes
and cultured under selection with 2 mg/mL Blasticidin S for 14 d to obtain
single colonies. The fixed fraction was stained against GFP and DAPI and the
number of GFP-positive cells was determined using a Zeiss microscope and
MetaCyte software (MetaSystems). For the cultured fraction, single colonies
were fixed with methanol:acetic acid (3:1) and stained with crystal violet.
Blasticidin-resistant colonies were counted and represented the LTGC frac-
tion of the GFP-positive HR events.
BrdU Incorporation Assay. To measure DNA repair synthesis in G2 cells, a
specialized BrdU assay was employed. As described previously, incorporation
of BrdU following IR can be visualized as foci arising in G2 cells which are
dependent on HR factors, but are not impeded by NHEJ factor depletion (23).
Briefly, cells were seeded and transfected with siRNA and 48 h later, were
labeled with 10 μM EdU for 1 h and irradiated with 4 Gy. Cells were then
washed with PBS and incubated with 50 μM BrdU and fixed after 8 h. To
allow access of antibodies to the incorporated BrdU, DNA was denatured
with 2.5 M HCl for 20 min at RT and the cells were washed thoroughly (10
times) with PBS. Staining was performed as described and BrdU foci were
manually enumerated in G2 cells.
Sister Chromatid Exchange Analysis. HeLa WT, HeLa ATRX KO, U2OSATRX, and
82-6 cells were transfected with siCtrl or siRECQ5 and incubated with 50 μM
BrdU for 48 h. Cells were irradiated with 2 Gy and then, 3 h prior to fixation,
were treated with 20 mg/mL caffeine and 10 mg/mL colcemid to enrich for
mitotic cells. HeLa cells were collected after 8 h post IR and U2OSATRX cells
were collected after 16 h due to slower exit from G2 into M phase (SI Ap-
pendix, Fig. S2C). The 82-6 cells were treated with 100 nM of the Chk1 in-
hibitor UCN-01 for 3 h instead of caffeine and collected at 12 h post IR to
obtain sufficient mitotic cells. For preparation of chromosome spreads, cells
were collected and resuspended in prewarmed 75 mM KCl for 30 min at
37 °C. Cells were then fixed with ice-cold methanol:acetic acid (3:1) three
times and chromosomes were spread onto coverslips and air dried overnight.
To obtain the differential staining between the two sister chromatids, slides
were washed, incubated with 5 μg/mL bisbenzimid (Hoechst 33258) for 1 h,
and then covered with 200 mM Na2HPO4 and 4 mM citric acid buffer (pH 7.1
to 7.2) and irradiated with ultraviolet light C at 9 J/cm2. Slides were then
washed in 2× saline-sodium citrate buffer at 50 °C for 30 min and stained
with Giemsa. Chromosome spreads were captured and analyzed using a
Zeiss microscope with Metafer software (MetaSystems).
Immunoblotting. Cells were lysed in Laemmli buffer [10% sodium dodecyl
sulfate (SDS), 300 mM Tris-HCl, 10 mM β-mercaptoethanol, 50% glycine,
0.02% bromophenol blue]. Protein extracts were loaded in equal amounts
for SDS-polyacrylamide gel electrophoresis and the separated proteins were
transferred to a nitrocellulose membrane, blocked for 1 h at RT in Rotiblock
(Roth) and incubated with primary antibodies overnight at 4 °C (anti-RECQ5,
Abcam, ab91422 and ab224135 and anti-GEN1, Abgent, AP9493a and the
antibodies described above). Membranes were then washed with 0.1%
tween-tris-buffered saline and incubated with horseradish peroxidase-
conjugated secondary antibodies for 1 h at RT. Immunoblots were devel-
oped using WesternBright Quantum or Sirius Kits (Advansta) and signal
detection was performed with Fusion FX system (VilberLourmat).
Quantification and Statistical Analysis. Unless otherwise specified, all data
were derived from at least n = 3 replicates and for each experiment at least
40 nuclei or 25 chromosome spreads were analyzed. Background foci were
subtracted from the mean values. Column plots show the mean value and
the error bars show the SEM between the experiments. P values were
obtained by Student’s t test and compare the mean values of independent
experiments (*P < 0.05; **P < 0.01; ***P < 0.001).
Data Availability. All study data are included in the article and supporting
information.
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